← Open Payments lookup

DEBRA BARNETT: Open Payments

NPI 1609921543 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,894 in 47 payments from 13 companies in 2025. Trend: 2023 $8,566 · 2024 $1,995 · 2025 $1,894

Food & beverage: $1,894
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$417
Otsuka America Pharmaceutical, Inc.9$340
Neuronetics, Inc.4$271
Vanda Pharmaceuticals Inc.5$223
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$208
Indivior Inc.3$159
Lundbeck LLC4$102
ABBVIE INC.5$89
Neurocrine BioSciences, Inc.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$17

Products named: REXULTI, COBENFY, NEUROSTAR TMS THERAPY SYSTEM, CAPLYTA, SUBLOCADE, HETLIOZ, FANAPT, VRAYLAR.

Industry payments across FL — which companies pay providers there.